Oncology & Cancer

The effect of breast cancer screening is declining

Screening for breast cancer has a cost. This is shown by a Danish/Norwegian study, published in the European Journal of Public Health, that analyzed 10,580 breast cancer deaths among Norwegian women aged 50 to 75 years.

Oncology & Cancer

New antibody therapies fight cancer, drum up investment

Antibody therapies are offering promising treatment breakthroughs for cancer and other illnesses, generating greater investor interest more than 20 years after they were first commercialized.


Breast cancer drug could help more patients

For the first time, a drug targeting a protein that drives breast cancer growth has been shown to work against tumors with very low levels of the protein.

page 1 from 40